Biofocus DPI: Galapagos Biofocus DPI


At BioFocus DPI​, our aim is to expand our partners' drug pipeline by accelerating the gene-to-preclinical-candidate discovery process. We achieve this by offering a biologically-focused discovery platform with two key differentiators - target discovery in human primary cells and chemogenomically-designed compound libraries. Through full-length cDNA and shRNA constructs, BioFocus' genome-wide screening approach can be applied across a broad range of disease areas to rapidly identify and validate disease-modifying drug targets. Once a target has been selected, BioFocus DPI focused small-molecule libraries, which target particular classes of proteins such as ion channel, kinase, or GPCR targets, are excellent tools for hit generation.

Related resource